BMP-4 and fetuin A in systemic sclerosis patients with or without calcinosis
2024

BMP-4 and fetuin A in systemic sclerosis patients with or without calcinosis

Sample size: 51 publication 10 minutes Evidence: moderate

Author Information

Author(s): Lofaro Francesco Demetrio, Giuggioli Dilia, Bonacorsi Susanna, Orlandi Martina, Spinella Amelia, De Pinto Marco, Secchi Ottavio, Ferri Clodoveo, Boraldi Federica

Primary Institution: University of Modena and Reggio Emilia, Modena, Italy

Hypothesis

The study aims to compare clinical and laboratory parameters in systemic sclerosis patients with and without cutaneous calcinosis and evaluate circulating markers related to calcification.

Conclusion

The study found significant differences in clinical manifestations and higher serum levels of BMP-4 in systemic sclerosis patients with calcinosis.

Supporting Evidence

  • Patients with calcinosis had a higher global score of clinical manifestations.
  • Serum levels of BMP-4 were significantly higher in patients with calcinosis.
  • Fetuin A showed a negative correlation with the global score in patients with calcinosis.
  • Statistically significant differences were found in the prevalence of certain clinical manifestations between the two groups.

Takeaway

This study looked at women with a disease called systemic sclerosis to see how many had a painful skin condition called calcinosis, and found that those with calcinosis had higher levels of a certain protein in their blood.

Methodology

An observational study comparing clinical and laboratory parameters in 51 female patients, 25 with calcinosis and 26 without, including serum calcification potential measurements.

Potential Biases

Potential bias due to the small sample size and exclusion of male patients.

Limitations

The study had a relatively small number of patients, lacked data in early disease phases, and did not include male patients.

Participant Demographics

All participants were female patients with systemic sclerosis.

Statistical Information

P-Value

p=0.0003 for ACA positivity, p=0.0047 for Scl70 positivity, p=0.0064 for global score.

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fimmu.2024.1502324

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication